Lexicon Pharmaceuticals Inc (LXRX) — Cash Flow Reinvestment Rate
Lexicon Pharmaceuticals Inc (LXRX) has a Cash Flow Reinvestment Rate of 0.91x as of June 2025, reinvesting $15.48 Million (capex $0.00 plus investments $15.48 Million) from operating cash flow of $16.99 Million. Explore Lexicon Pharmaceuticals Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Lexicon Pharmaceuticals Inc Cash Flow Reinvestment Rate (2005–2019)
Historical reinvestment intensity for Lexicon Pharmaceuticals Inc across 3 annual periods. Also explore Lexicon Pharmaceuticals Inc assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Lexicon Pharmaceuticals Inc (2005–2019)
Year-by-year capital reinvestment analysis for Lexicon Pharmaceuticals Inc. For live market cap and broader valuation context, see Lexicon Pharmaceuticals Inc (LXRX) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 1.37x | $155.85 Million | $113.81 Million | $70.00K | ▲ +115.6% |
| 2015 | 0.64x | $117.36 Million | $184.78 Million | $910.00K | ▲ +32.0% |
| 2005 | 0.48x | $11.28 Million | $23.44 Million | $11.28 Million | — |